ID
41471
Beskrivning
Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. In this form (Status, Adverse Events Status) the occurrence of adverse events and the status of COPD is to be documented during the study.
Länk
https://clinicaltrials.gov/ct2/show/NCT00784550
Nyckelord
Versioner (1)
- 2020-10-21 2020-10-21 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
21 oktober 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550
Status, Adverse Events Status
- StudyEvent: ODM
Beskrivning
Status
Alias
- UMLS CUI-1
- C0449438
Beskrivning
COPD medication during study
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0024117
- UMLS CUI [1,2]
- C0013227
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C0347984
Beskrivning
Concomitant medications during study
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beskrivning
COPD exacerbation during study
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0740304
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beskrivning
Lower respiratory tract infection requiring antibiotics treatment
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0149725
- UMLS CUI [1,2]
- C1514873
- UMLS CUI [1,3]
- C0003232
- UMLS CUI [1,4]
- C0008976
- UMLS CUI [1,5]
- C0347984
Beskrivning
AE Status
Alias
- UMLS CUI-1
- C0877248
Beskrivning
Non-serious adverse events during study
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Beskrivning
Serious adverse event during study
Datatyp
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0008976
- UMLS CUI [1,3]
- C0347984
Similar models
Status, Adverse Events Status
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,4])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0003232 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0347984 (UMLS CUI [1,5])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])